Related Experiment Video
Updated: May 11, 2026
08:13
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
[Type 2 diabetes and impaired glucose tolerance]
Noboru Furukawa1, Eiichi Araki
1Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University.
Summary
Lifestyle changes in Japan increase type 2 diabetes in obese individuals. Japanese individuals may develop diabetes with milder obesity due to lower insulin secretion capacity, requiring strict lifestyle changes and specific medications.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Public Health
Context:
- Increasing prevalence of type 2 diabetes in Japan linked to lifestyle changes and obesity.
- Obesity-induced alterations in adipokines (e.g., decreased adiponectin, increased TNF-alpha) contribute to insulin resistance.
- Potential lower insulin secretory capacity in Japanese pancreatic beta cells compared to Caucasians, predisposing to diabetes with milder obesity.
Purpose:
- To highlight the unique challenges in managing type 2 diabetes in the context of obesity among the Japanese population.
- To discuss the pathophysiological mechanisms linking obesity, adipokine dysregulation, and insulin resistance in this demographic.
- To outline appropriate therapeutic strategies, including lifestyle modifications and pharmacotherapy.
Summary:
- Rising obesity in Japan correlates with increased type 2 diabetes, driven by adipokine imbalance and insulin resistance.
- Japanese individuals may be more susceptible to diabetes with less severe obesity due to inherent differences in pancreatic beta-cell function.
- Effective management necessitates stringent diet and exercise, alongside medications targeting insulin resistance, such as biguanides, thiazolidine derivatives, DPP-4 inhibitors, and GLP-1 analogues.
Impact:
- Informs clinical practice regarding tailored treatment approaches for type 2 diabetes in obese Japanese patients.
- Contributes to understanding the interplay of genetics, lifestyle, and metabolic health in diabetes development.
- Emphasizes the importance of personalized medicine in addressing the growing burden of obesity-related metabolic diseases.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...